Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death. by Grasso, Daniel Hector et al.
Zymophagy, a Novel Selective Autophagy Pathway Mediated
by VMP1-USP9x-p62, Prevents Pancreatic Cell Death*
Received for publication,October 26, 2010, and in revised form, December 9, 2010 Published, JBC Papers in Press,December 20, 2010, DOI 10.1074/jbc.M110.197301
Daniel Grasso‡1, Alejandro Ropolo‡, Andrea Lo Re´‡2, Vero´nica Boggio‡, María I. Molejo´n‡3, Juan L. Iovanna§,
Claudio D. Gonzalez‡, Rau´l Urrutia¶, and María I. Vaccaro‡4
From the ‡Department of Pathophysiology, School of Pharmacy and Biochemistry, University of Buenos Aires, C1113AAD Buenos
Aires, Argentina, the §Unite´ 624, INSERM, 13288Marseille, France, and the ¶Chromatin Dynamics and Epigenetic Laboratory, Mayo
Clinic, Rochester, Minnesota 55905
Autophagy has recently elicited significant attention as a
mechanism that either protects or promotes cell death, al-
though different autophagy pathways, and the cellular context
in which they occur, remain to be elucidated. We report a
thorough cellular and biochemical characterization of a novel
selective autophagy that works as a protective cell response.
This new selective autophagy is activated in pancreatic acinar
cells during pancreatitis-induced vesicular transport alteration
to sequester and degrade potentially deleterious activated zy-
mogen granules. We have coined the term “zymophagy” to
refer to this process. The autophagy-related protein VMP1,
the ubiquitin-protease USP9x, and the ubiquitin-binding pro-
tein p62 mediate zymophagy. Moreover, VMP1 interacts with
USP9x, indicating that there is a close cooperation between
the autophagy pathway and the ubiquitin recognition machin-
ery required for selective autophagosome formation. Zy-
mophagy is activated by experimental pancreatitis in geneti-
cally engineered mice and cultured pancreatic acinar cells and
by acute pancreatitis in humans. Furthermore, zymophagy has
pathophysiological relevance by controlling pancreatitis-in-
duced intracellular zymogen activation and helping to prevent
cell death. Together, these data reveal a novel selective form of
autophagy mediated by the VMP1-USP9x-p62 pathway, as a
cellular protective response.
Autophagy is an evolutionarily preserved cellular process
that is responsible for the degradation of long lived proteins
and entire organelles to maintain intracellular homeostasis
and to contribute to starvation and stress responses. Mac-
roautophagy involves the formation of double-membrane
autophagosomes around cargoes, including larger structures
such as organelles and protein aggregates. Autophagosomes
then fuse with lysosomes, where the degradation of the car-
goes takes place. Both nonselective “bulk” autophagy and se-
lective autophagy of specific proteins and organelles have
been described (1). Genetic analyses in yeast identified more
than 30 conserved components that are required for different
steps of autophagy (termed Atg1 to Atg32) (2). Several lines of
evidence suggest the existence of different types of selective
autophagic degradation pathways. Single proteins and cellular
structures such as protein aggregates, peroxisomes, ribo-
somes, and mitochondria can be specifically engulfed by au-
tophagosomes (3), but the mechanism of cargo recognition is
not well understood. However, there is emerging evidence
suggesting the involvement of ubiquitin in this process. For
example, aggregate clearance by autophagy requires ubiquity-
lation and ubiquitin-binding receptors such as p62 (also
known as SQSTM1) (4). Ubiquitylated artificial substrates are
recognized by the autophagy machinery and are specifically
degraded in lysosomes by a p62-dependent mechanism (5).
Moreover, the selective degradation of excess ribosomes dur-
ing starvation depends on the deubiquitylation activity of
Ubp3/Bre5 (6). However, the repertoire of proteins that par-
ticipate in these ubiquitin-mediated pathways during different
types of autophagy remains an area of intensive investigation,
particularly to elucidate the role of this specific cellular pro-
gram in pathophysiological processes, such as defects in vesic-
ular traffic in pancreatitis.
We have previously reported the identification of the vacu-
ole membrane protein-1 (VMP1) in pancreatitis affected aci-
nar cells and positioned it as a new autophagy-related protein.
VMP1 induces autophagosome formation, even under nutri-
ent-replete conditions while remaining an integrated au-
tophagosomal membrane protein in mammalian cells (7).
VMP1 interacts with Beclin 1/ATG6 through its hydrophilic
C-terminal region (VMP1-Atg domain), which is necessary
for early steps of autophagosome formation (7). The latter has
also been reported by Tian et al. (8) by identifying EPG-3/
VMP1 as one of three essential autophagy genes conserved
from worms to mammals, which regulates early steps of the
autophagic pathway in Caenorhabditis elegans. Hierarchical
analyses in mammalian cells by Itakura and Mizushima (9)
showed that VMP1 along with ULK1 and Atg14 localize in
the endoplasmic reticulum-associated autophagosome forma-
tion sites in a PI3K activity-independent manner, confirming
the key role of VMP1 in the formation of autophagosomes.
Interestingly, Dictyostelium cells lacking Vmp1 gene showed
accumulation of huge ubiquitin-positive protein aggregates
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containing the autophagy marker Atg8/LC3 and p62 homolog
(10). Despite the progress made in VMP1-mediated au-
tophagy, whether this process cooperates with the ubiquitin
pathway remains to be firmly established.
The pancreatic acinar cell is a highly polarized, differenti-
ated cell whose primary function is the synthesis and secre-
tion of digestive enzymes into the pancreatic juice. Pancreatic
digestive enzymes are produced as inactive enzymes (zymo-
gens) and stored in subcellular structures called zymogen
granules, until exocytosis. Zymogen granules are potentially
harmful because activated digestive enzymes are able to hy-
drolyze tissue parenchyma. Acute pancreatitis, defined as the
pancreas self-digestion, is the most frequent disease of the
pancreas. During pancreatitis, ultrastructural alterations of
zymogen granules are produced in a yet undefined way. These
alterations are characterized by premature activation of tryp-
sinogen to trypsin within pancreatic acinar cells leading to the
progression of the disease (11). We have previously demon-
strated that VMP1 autophagic vesicles are present in the pan-
creas of rats submitted to experimental pancreatitis (7), sug-
gesting that VMP1 is involved in the induction of autophagy
during the disease. Considering that autophagy is implicated
in several pathological mechanisms operating in human dis-
eases, it remains unknown whether the VMP1 pathway regu-
lates potential pathophysiological processes.
Cholecystokinin is a pancreatic secretagogue that interacts
with Gq-coupled receptors in the acinar cell to induce pancre-
atic secretion in physiological conditions. However, the hy-
perstimulation of cholecystokinin receptors (CCK-R)5 with
the analog cerulein modifies vesicular transport and leads to
intracellular proteolytic enzyme activation and ultimately cell
death (12). These cellular events are characteristic of acute
pancreatitis. Therefore, in this study, we use this secreta-
gogue-induced model because it is the most commonly em-
ployed and best characterized model of acute pancreatitis
(12).
The results from our work describe the critical function of
autophagy in secretory granule homeostasis and cell response
to injury by the selective degradation of altered secretory
granules in acute pancreatitis. This process, which we define
as “zymophagy,” can be induced by the hyperstimulation of
CCK-R in a transgenic mouse model for studying VMP1-in-
duced autophagy in pancreatic acinar cells (ElaI-VMP1 mice).
Zymophagy degrades the activated granules avoiding the re-
lease of their contents into the cytoplasm, thus preventing
further trypsinogen activation and cell death. We report that
the ubiquitin-binding protein p62, which is a cargo receptor
for selective autophagy, participates in VMP1-mediated au-
tophagy. We also describe in ElaI-VMP1 mice the immuno-
magnetic isolation of autophagosomes containing zymogen
granules induced by CCK-R hyperstimulation. Furthermore,
we demonstrate that zymophagy requires a physical interac-
tion between the ubiquitin-protease USP9x and VMP1, sup-
porting a previously unidentified key role for the ubiquitin
pathway. We also show the induction of VMP1 expression
and zymophagy in human pancreas affected by acute pancrea-
titis. These results demonstrate a previously unrecognized
function for VMP1, mediating zymophagy, a novel selective
form of autophagy, which functionally links the autophagy
pathway with the ubiquitin machinery to trigger a protective
response to cell death.
EXPERIMENTAL PROCEDURES
Transgenic Mice (ELAI-VMP1 Mice)—The transgene cas-
sette was made using the pBEG vector (7, 13). The expression
cassette contains the acinar-specific control region (500 to
8) from the rat elastase I gene and the human growth hor-
mone 3-untranslated region (UTR) (500 to2657). This
construct was digested with BamHI, filled in, dephosphory-
lated, and ligated with rat VMP1-EGFP released from pEGFP-
VMP1 plasmid. A 1940-kb HindIII/NotI fragment was iso-
lated and used for microinjections into inbred FVB zygotes.
Genomic DNA was prepared and tested by Southern blot and
PCR.
Cerulein-induced Pancreatitis—Male C57BL6J and
C57BL6J-ElaI-VMP1 mice weighing 20–25 g were used. Ani-
mals were housed with free access to food and water. Experi-
ments were performed according to the standard ethical and
legal guidelines of the University of Buenos Aires regulations
for animal experiments. Pancreatitis was induced by seven
intraperitoneal injections of cerulein (Sigma) (50 g/kg) given
at 1-h intervals; mice were killed by decapitation at different
times after the first injection. In one series of experiments, the
pancreata were removed, homogenized in HEPES buffer, pH
7.4, containing protease inhibitors (0.5 mM PMSF, 5 g/ml
pepstatin, 5 g/ml leupeptin, and 2.5 g/ml aprotinin), and
processed for Western blot analysis. In another series of ex-
periments, the pancreata were removed and fixed in 4% p-
formaldehyde for histological analysis or in 2.5% glutaralde-
hyde for electron microscopy.
Transmission Electron Microscopy—Samples were fixed and
processed for transmission electron microscopy by standard
procedures. Grids were examined under a Carl Zeiss C-10
electron microscope (LANAIS-MIE, UBA).
Antibodies—Polyclonal rabbit antiserum to VMP1 against
the peptide MAQSYAKRIQQRLNSEEKTK (residues 385–
406) was obtained and used at 1:100 dilution. Polyclonal goat
anti-LC3, goat anti-p62, goat anti-USP9x, goat anti-Lamp2,
rabbit anti-trypsinogen, goat anti-amylase, monoclonal mouse
anti-GFP antibody (Santa Cruz Biotechnology), andmonoclonal
mouse anti-V5 (Invitrogen) antibodies were used according to
themanufacturer. Alexa Fluor 488 and 594 antibodies (Molecu-
lar Probes) were used for immunofluorescence assays. Peroxi-
dase-labeled anti-rabbit and anti-goat IgG antibodies were used
forWestern blot according to GEHealthcare.
VMP1-EGFP-coated Vesicle Immunoisolation—Enriched
organelle fractions were isolated from ElaI-VMP1 mouse pan-
creata according to the separate methods of Cox and Emili
(14) with some modifications. Mouse pancreata were re-
moved and immediately homogenized in 1 ml of ice-cold 250-
STM buffer (250 mM sucrose, 50 mM Tris, pH 7.4, 5 mM
MgCl2, plus 1 mM PMSF, 10 g/ml leupeptin, 0.5 mg/ml soy-
5 The abbreviations used are: CCK-R, cholecystokinin receptor; BZiPAR, rho-
damine 110 bis-(CBZ-L-isoleucyl-L-prolyl-L-arginine amide) dihydrochlo-
ride; 3-MA, 3-methyladenine; EGFP, enhanced GFP.
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bean trypsin inhibitor, 20 nM aprotinin, 1 g/ml pepstatin,
and 1 mM benzamidine). The homogenate was centrifuged at
800 g for 10 min to obtain a postnuclear supernatant. Im-
munoisolations were done as reviewed by Howell et al. (15).
Briefly, tosylated superparamagnetic beads (Dynabeads
M-500 Subcellular; Dynal Inc.) were incubated overnight at
room temperature on a rotator with a rabbit anti-mouse
linker antibody (ZyMax, Zymed Laboratories Inc., Invitrogen)
at a concentration of 10 g of Ab/mg beads in borate buffer
(10 mM H3B3, pH 9.5). For this and all subsequent steps,
beads were collected with a magnetic device (MPC, Dynal
Inc.). Beads were rinsed with incubation buffer (PBS contain-
ing 2 mM EDTA, 5% FBS) for 30 min, Tris buffer (50 mM Tris,
pH 7.8, 100 mM NaCl, 0.1% Tween 20, 0.05% BSA) for 60 min,
and incubation buffer for 30 min. Coated Dynabeads (2–10
mg) were incubated for 12 h on a rotator with mouse anti-
GFP monoclonal antibody (Santa Cruz Biotechnology) at a
concentration of 10 g/mg beads diluted in incubation buffer
to a final volume of 1 ml. To obtain beads for control experi-
ments, coated beads were incubated as above in incubation
buffer alone. Beads (2–10 mg) were rinsed with two changes
of incubation buffer and then incubated overnight at 4 °C on a
rotator with 0.15–0.25 mg of postnuclear supernatant (25–30
g of protein/mg of beads) in 1 ml of incubation buffer. Beads
were then collected, rinsed with incubation buffer, and saved
as the inmunoisolated fractions and alternatively processed by
standard transmission electron microscopy technique or by
Western blot assay. To quantify immunoisolated autophago-
somes, 100 magnetic beads were evaluated, and all beads at-
tached to vesicles were counted. The vesicles were classified
as empty vesicles (empty or unspecific cargo containing vesi-
cles) or zymogen granules containing vesicles. Results were
expressed as percentage of total number of vesicles counted
and represented as mean S.D. of three independent
experiments.
Pancreatic Acini Isolation—Pancreatic acini were prepared
by collagenase digestion of pancreata and suspended in
HEPES-Ringer buffer with Eagle’s minimal essential amino
acids, 1 mg/ml BSA, and equilibrated with 100% O2. Viability
of acini was 95% based on trypan blue exclusion (16). In vitro
cerulein-induced amylase secretion was made as acini func-
tional evaluation. Acini from both ElaI-VMP1 and wild type
mice were incubated at 37 °C with varying concentrations of
cerulein for 30 min. Amylase secretion into the medium and
total amylase content of the samples were measured. Net
stimulated amylase secretion was calculated as the difference
between the percentage of total amylase secreted in the pres-
ence and absence of cerulein (17). An in vitro CCK-R hyper-
stimulation model of acute pancreatitis was performed by
incubating dispersed pancreatic acini at 37 °C in HEPES-
Ringer buffer with 100 nM cerulein (18). Alternatively, acini
were incubated with 0.1 nM chloroquine or 0.05 nM vinblas-
tine (Sigma) before being subjected to CCK-R
hyperstimulation.
Immunofluorescence Assays—After cerulein treatment, iso-
lated acini and differentiated AR42J cells were fixed during 15
min with 4% p-formaldehyde in PBS and immediately washed
several times with PBS. Acini were incubated with primary
antibodies overnight at 4 °C, according to the manufacturer.
Samples were mounted in 1,4-diazabicyclo[2.2.2]octane
(Sigma) with DAPI (Sigma) as the nuclear marker and ob-
served in an inverted LSM Olympus FV1000 using an
UPLSAPO 60X O NA: 1.35 objective.
Histological Studies—Quantification of inflammatory infil-
tration was performed on pancreatic tissue sections stained
with hematoxylin and eosin (H&E) and expressed as inflam-
matory cells per 100 acinar cells. Alternatively, tissues were
fixed in 1% glutaraldehyde in 0.1 M phosphate buffer and
stained with 1% toluidine blue in borax for necrosis quantifi-
cation. Cells with swollen cytoplasm, loss of plasma mem-
brane integrity, and leakage of organelles into interstitium
were considered necrotic; and results expressed as necrotic
cells per 100 acinar cells.
Trypsin Activity Assays—Fluorescent microscopy for obser-
vation of trypsin activity, isolated acini, and differentiated
AR42J cells were incubated 20 min in extracellular solution
containing 100 M rhodamine 110 bis-(CBZ-L-isoleucyl-L-
prolyl-L-arginine amide) dihydrochloride (BZiPAR) (Invitro-
gen) in HEPES buffer, pH 7.5, and observed immediately. To
quantify the trypsin activity, isolated pancreatic acini and dif-
ferentiated AR42J cells were lysed, and 20 g of protein of
each sample were mixed with 100 l of 4 mM trypsin sub-
strate butoxycarbonyl-Gln-Ala-Arg-7-amido-4-methylcou-
marin hydrochloride (Sigma), in trypsin reaction buffer (10
mM Tris, 20 mM CaCl2, pH 7.4), and then incubated 30 min at
37 °C. The fluorescence intensity from trypsin substrate was
measured at 450 nm in a fluorescence microplate reader un-
der excitation at 380 nm.
Myeloperoxidase Quantification—Myeloperoxidase activity
was measured to quantify neutrophil sequestration. Enzy-
matic extracts were prepared from pancreas homogenates as
described by Dawra et al. (19). Myeloperoxidase activity was
determined by spectrophotometric method with 3,3,5,5-
tetramethylbenzidine at 655 nm of absorbance (20).
Differentiated AR42J Acinar Cells, Transfections and
Treatments—Rat pancreatic acinar AR42J cells (pancreatoma,
ATCC CRL 1492) were cultured in Dulbecco’s modified Ea-
gle’s medium (Hyclone) supplemented with 10% fetal bovine
serum (Invitrogen) and antibiotics (100 units/ml penicillin
and 100 g/ml streptomycin). For differentiation induction,
cells were treated with dexamethasone (Sigma) at a final
concentration of 100 nM for 48 h (21). Cells were transfected
using FuGENE 6 reagent (Roche Applied Science) with the
following plasmids: pcDNA4-V5-His (Invitrogen); pEGFP-N1
(Clontech) containing full-length rat VMP1 cDNA
(NM_138839); pRFP-C1 containing full-length rat LC3 kindly
provided by Dr. María I. Colombo (UNCu-CONICET, Argen-
tina); GFP-Ub (Addgene plasmid 11928) (22) and mRFP-Ub
(Addgene plasmid 11935) (23) from Dr. Nico Dantuma (Karo-
linska Institutet, Sweden). VMP1 and USP9x down-regulation
was made by the plasmid pCMS3-H1p-EGFP, which was
kindly provided by Dr. D. Billadeau (Department of Immunol-
ogy, College of Medicine, Mayo Clinic). The plasmid contains
a short hairpin RNA construction (for VMP1, sense 5-GGC-
AGAAUAUUGUCCUGUGtt-3 and antisense 5-CACAGG-
ACAAUAUUCUCUGCCtt-3; for USP9x, sense 5-TCCGA-
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TGAGGAACCTGCATtt-3 and antisense 5-ATGCAGGTT-
CCTCATCTTT-3) or a scramble sequence and a separate
transcriptional cassette for EGFP to identify transfected cells
(24). Differentiated cells were treated with 7.5 M cerulein
(Sigma) to induce CCK-R hyperstimulation. For autophagy
inhibition, cells were treated with 10 mM 3-methyladenine
(3-MA) (Sigma) 2 h before and during experiments. The effi-
cacy of 3-MA treatment was verified on starved cells (data not
shown). Starvation-induced autophagy was stimulated by
amino acid/serum-deprived medium using Earle’s balanced
salts (Invitrogen). For lysosomal hydrolase inhibition, cells
were treated with 0.1 nM chloroquine (Sigma) for 1 h before
assays.
Percentage of Cells with Punctate LC3 Staining—The per-
centage of cells with punctate LC3 staining was determined
in three independent experiments and expressed as the
mean S.D. of combined results. To quantify cells with LC3
punctate staining, six random fields representing 100 cells
were counted. We consider a cell with punctate LC3 staining
when all the LC3 fluorescence is present as punctate and no
diffused protein remain. For human pancreas specimens, an
arbitrary classification among heterogeneous tissue areas was
made before quantification. A0 was assigned to tissue areas
where acini were present in normal morphology. A1 was as-
signed to affected areas in which edema, cell detachment, and
loss of cell polarity were observed. The quantification of au-
tophagy in human specimens was performed as a percentage
of cells with both VMP1-positive staining and punctate LC3,
per 100 acinar cells in A0 and A1 areas. Staining was counted
in six random fields and expressed as mean S.D. of three
independent experiments.
Coimmunoprecipitation Assays—Dexamethasone-differenti-
ated AR42J cells were transfected with pcDNA4-VMP1-V5-His6
expression plasmid. Cells were lysed (Lysis buffer: 50 mM
Na2HPO4, 300 mM NaCl, pH 8.0, 0.5% Tween 20, 0.5% Triton
X-100, 10 mM imidazole), and cell lysates were incubated with
50 l of nickel-nitrilotriacetic acid beads (Qiagen) for 3 h at
room temperature; afterward, the supernatant was removed
and saved as unbound fraction (S1). nickel-nitrilotriacetic
acid beads were intensively washed with lysis buffer and 20
mM imidazole (the second wash was saved as W2). The bound
proteins were eluted by lysis buffer supplemented with 200
mM imidazole (E1). Samples were resolved on SDS-PAGE and
detected by the appropriate antibodies. For coimmunopre-
cipitation of endogenous proteins, cell were lysed in lysis
buffer containing 137 mM NaCl, 2 mM EDTA, 10% glycerol,
1% Nonidet P-40, 20 mM Tris, pH 8.0, and 5% (v/v) protease
inhibitor mixture (Sigma). After preclearance by centrifuga-
tion at 14,000 rpm for 10 min, the extracts were incubated
with anti-VMP1 antibody at 4 °C overnight. The immuno-
complexes were captured by protein G-Sepharose beads
(Amersham Biosciences), which were washed five times with
lysis buffer. The bound proteins were eluted by 5 SDS sam-
ple buffer at 100 °C for 5 min, resolved on SDS-PAGE, and
detected by the anti-USP9x antibody (Santa Cruz
Biotechnology).
Human Pancreas Specimens—Samples were kindly pro-
vided by Dr. Ana Cabane from the Pathology Department, Dr.
Carlos Bonorino Udaondo Gastroenterology Hospital, and the
study was approved by the Institutional Review Board.
Statistics—Experimental groups were compared using t test
for pairwise comparisons. For all experiments, statistical sig-
nificance is indicated as follows: NS, nonsignificant; *, p
0.05; **, p 0.001.
RESULTS
Hyperstimulation of CCK-R in Acinar Cells Induces the For-
mation of Autophagosomes Containing Zymogen Granules
and the Redistribution of VMP1—We initially employed cellu-
lar and biochemical tools to characterize the cargo of VMP1-
mediated autophagosomes in the context of CCK-R hyper-
stimulation with cerulein, as a model of pancreatitis. We
developed the ElaI-VMP1 mouse in which acinar cell-specific
constitutive expression of a VMP1-EGFP chimera induces the
formation of autophagosomes (7). We used this unique tool to
investigate the role of the VMP1 pathway in autophagy. The
ultrastructural features of pancreatic acinar cells from ElaI-
VMP1 and wild type mouse specimens, before and after
CCK-R hyperstimulation, were studied by electron micros-
copy (EM). In the untreated mice, both wild type and ElaI-
VMP1, acinar cells showed secretory granules with normal
ultrastructural characteristics (Fig. 1A). CCK-R hyperstimula-
tion in wild type animals induced a markedly altered distribu-
tion pattern of the secretory granules. Fig. 1B shows intracel-
lular fusion among zymogen granules as well as their fusion
with condensing vacuoles. In addition, acinar cells lose their
polarity, which results in the relocation of zymogen granules
to the basolateral membrane (Fig. 1B). All these alterations in
vesicular traffic are known to occur in acinar cells during
acute pancreatitis and upon hyperstimulation of their CCK-R
with cerulein. A comparative EM analysis of ElaI-VMP1 mice
subjected to CCK-R hyperstimulation revealed that acinar
cells preserve their structure and polarity with negligible or
no alteration in vesicular transport. Surprisingly, in pancreata
from cerulein-treated ElaI-VMP1 mice, we observed autopha-
gosomes containing zymogen granules displaying a distinct
localization to the apical area of the acinar cell. These au-
tophagosomes, containing secretory granules, were easily
identifiable in apical regions as round high density structures
within double membrane vesicles (Fig. 1, C–E). After a sys-
tematic observation, we did not find evidence of other subcel-
lular structures, such as ribosomes or mitochondria, within
these autophagosomes. These studies also showed different
maturation levels of selective autophagic vesicles, providing
evidence that autophagic flow remains primarily unchanged
under CCK-R hyperstimulation. Examples of large autopha-
gosomes containing morphologically altered zymogen gran-
ules and autolysosomes with partially degraded zymogen
granules are shown in Fig. 1F. Therefore, in acinar cells from
the ElaI-VMP1 mice, CCK-R hyperstimulation induces a pro-
gressive flow of autophagic vesicles containing zymogen gran-
ules that accumulate at the apical pole of acinar cells. Subse-
quently, we determined the integrity of the mammalian
protein p62 (25, 26), which is selectively degraded by auto-
phagy (4). Western blot analysis showed that p62 displays a
markedly increased degradation rate in treated ElaI-VMP1
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FIGURE 1.Hyperstimulation of CCK-R in acinar cells induces the redistribution of zymogen granules and VMP1-containing autophagosomes.
A–F, transmission electron microscopy of pancreatic tissue. A,wild type and ElaI-VMP1 mouse pancreata. No ultrastructural alteration is evident in zymogen
granules of acinar cells from ElaI-VMP1 compared with wild type mouse pancreata. B,wild type mouse pancreas after CCK-R hyperstimulation (detailed
on the right). Ultrastructural alterations of zymogen granules (arrowheads), fusion between zymogen granules and condensing vacuoles (arrow), and zymogen
granules appearing near basolateral dilated space are shown (*). C–F, ultrastructure of pancreatic tissue from ElaI-VMP1 mice after CCK-R hyperstimulation
with cerulein. C and D, autophagosomes containing zymogen granules are observed in the apical area of the acinar cell (dashed line). Zymogen granules
inside autophagosomes are detailed in C (bottom panel). Autophagosome-double membrane is detailed in D, bottom panel (arrowhead). E, left panel, exam-
ple of zymogen granules sequestered by autophagosome (arrow). Right panel, examples of autophagosomes containing one single zymogen granule (ar-
rowheads). F, examples of large autophagosomes and autolysosomes containing zymogen granules. Higher magnification is shown on the right upper
panel. At the bottom panel, the arrowheads show the limits of the single membrane autolysosomes (panels a and b) and large double membrane-limited
autophagosomes (panels c and d). G,Western blot analysis and densitometry quantification of p62 in ElaI-VMP1 mouse pancreas homogenates shows the
progressive reduction of the p62 signal evidencing autophagic flow in pancreas from transgenic mice under CCK-R hyperstimulation with cerulein (**, p
0.001 versuswild type). H, bright field, VMP1-EGFP fluorescence and merge images of isolated ElaI-VMP1 pancreatic acini. VMP1-EGFP fluorescence is lo-
cated in the basal region of untreated acini (upper panel). After 1 h of CCK-R hyperstimulation with cerulein, VMP1-EGFP relocated to the granular area of
acinar cells (bottom panel). Results are representative of at least three independent experiments. Scale bars, 4 m (A–F), and 10 m (H). BL, basolateral, AP,
apical, ZG, zymogen granules. N, nucleus.
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mouse pancreata compared with treated wild type mice (Fig.
1G). Thus, these results support the EM analysis described
above, suggesting that secretory granules are sequestered and
degraded by an autophagic pathway in acinar cells. In addi-
tion, it confirms the appropriate functionality of the auto-
phagic flow induced by CCK-R hyperstimulation in the ElaI-
VMP1 mouse pancreas.
To gain an insight into a potential codistribution of VMP1
with organelles, which may be the subject of autophagy, we
isolated pancreatic acini from ElaI-VMP1 mice. In these spec-
imens, VMP1 can be visualized by direct fluorescence of the
VMP1-EGFP chimera expressed in acinar cells. Interestingly,
similar to the case of in vivo autophagosomes, in vitro CCK-R
hyperstimulation of ElaI-VMP1 mouse isolated acini also in-
duced a subcellular change in VMP1 localization. Fig. 1H
shows that VMP1 was distributed at the basal region in un-
treated acinar cells, but after CCK-R hyperstimulation, VMP1
relocated to the zymogen granule-rich area (apical pole).
These results further suggest that under CCK-R hyperstimu-
lation, VMP1-containing autophagosomes relocate to the api-
cal pole to sequester zymogen granules.
Identification of an Inducible and Selective Degradation
Process of Zymogen Granules That Involves VMP1 and p62-
containing Autophagosomes—We investigated the functional
significance of the relocation of VMP1-containing autophago-
somes. We first performed immunofluorescence assays using
anti-LC3 to identify autophagosomes and anti-trypsinogen to
indicate zymogen granules. Fig. 2A shows that CCK-R hyper-
stimulation induced colocalization of LC3 and trypsinogen,
indicating that the VMP1-containing autophagosomes relo-
cate to sequester zymogen granules. To further confirm that a
VMP1-mediated autophagic process selectively sequesters
zymogen granules under CCK-R hyperstimulation, we per-
formed subcellular fractionation studies. We immunopurified
VMP1-mediated autophagosomes from ElaI-VMP1 mouse
pancreata using anti-GFP antibody bound to magnetic beads.
Fig. 2B shows that autophagosomes containing zymogen
granules were magnetically isolated from the pancreas of ElaI-
VMP1 mice treated with cerulein, whereas in untreated ani-
mals, either empty or cytoplasm-containing autophagosomes
were purified (Fig. 2C). Through quantitative analysis, we
found that in untreated animals less than 20% of the autopha-
gosomes contain zymogen granules, whereas in the cerulein-
treated ones, this percentage increases up to 70% (Fig. 2D).
Moreover, combined with Western blot analysis, this method
allowed us to further identify the cargo of VMP1 autophago-
somes. LC3-II, an autophagy-related protein that specifically
attaches to autophagosomal membranes, was present in the
autophagosomal fraction obtained from both cerulein-treated
and untreated specimens, further confirming that an auto-
phagic pathway is involved in the sequestration of zymogen
granules (Fig. 2E). Notably, strong signals of p62 and trypsino-
gen were found only in magnetically immunopurified au-
tophagosomes from cerulein-treated ElaI-VMP1 mice (Fig.
2E). This finding suggests that p62, which is a ubiquitin-bind-
ing protein that interacts with LC3 (4), may function as a
cargo receptor during the selective autophagic pathway. To-
gether, the results show that a nonselective autophagy path-
way, which involves LC3-II but not p62, is triggered by VMP1
expression in untreated mouse pancreata. On the other hand,
upon CCK-R hyperstimulation, p62 is involved in VMP1-me-
diated selective autophagy of zymogen granules. Thus, as we
mentioned earlier, we named this new process of selective
autophagy as zymophagy to differentiate it from other types
of autophagy.
Zymophagy Selectively Sequesters Activated Zymogen Gran-
ules to Prevent the Spreading of Activated Trypsin within the
Acinar Cell—To examine the functional relevance of zymo-
phagy, we examined the intracellular activation of trypsinogen in
isolated murine pancreatic acini. Isolated acini have been a
classical tool for studying organelle movement when vesicular
transport is altered by hyperstimulation of CCK-R as a model
of acute pancreatitis (15). During transport alteration, there is
a sustained increase of intracellular Ca2 concentrations lead-
ing to cytoplasmic autoactivation of trypsin in the acinar cell
(27). We measured trypsin activity as a surrogate marker for
zymogen granule activation, using rhodamine 110 bis-(CBZ-
L-isoleucyl-L-prolyl-L-arginine amide) dihydrochloride
(BZiPAR), a cell-permeable substrate that becomes fluorescent
after the cleavage by this protease (28–30). Trypsin activity
was detected by fluorescence of the hydrolyzed substrate
within isolated acini. Upon CCK-R hyperstimulation, acinar
cells from wild type mice showed early cytoplasmic trypsino-
gen activation (Fig. 3A). In contrast, acinar cells from ElaI-
VMP1 mice showed almost no activation of trypsinogen (Fig.
3B). These results suggest that the constitutive activation of
VMP1-mediated autophagy, characteristic of acinar cells from
ElaI-VMP1 mice, prevents intracellular trypsinogen activation
in acute pancreatitis. Fig. 3C shows the time course of trypsin-
ogen activation, expressed as a relative percentage of maximal
trypsin activity after CCK-R hyperstimulation. Under these
conditions, wild type acini displayed 45% of maximal trypsin
activity after 0.5 h of CCK-R hyperstimulation and reached
the 100% activation peak after 1 h. Conversely, acini from
ElaI-VMP1 mice only reached 34% of maximal trypsin activity
after 1 h treatment. Furthermore, microscopy examinations
revealed only few punctate structures containing hydrolyzed
substrate restricted to the granular area of acinar cells from
ElaI-VMP1 mice. These activated granules colocalized with
the VMP1-EGFP fluorescent signal (Fig. 3D). Therefore, our
results demonstrate that zymophagy is induced during pan-
creatic acinar cell injury to selectively sequester the activated
zymogen granules.
Zymogen activation is an enzymatic chain reaction where
initial zymogen granule alterations trigger the rapid spread of
active trypsin within the acinar cell. We hypothesized that the
degradation of early activated zymogen granules by zy-
mophagy prevents this deleterious event. To test this hypoth-
esis, we evaluated trypsin activity in isolated acini treated with
either vinblastine or chloroquine compounds that inhibit au-
tophagic flow by two different mechanisms as follows: inter-
ruption of autophagosome-lysosome fusion and inactivation
of lysosomal hydrolases, respectively. Thus, we quantified
trypsin activation after 1 h of CCK-R hyperstimulation in
ElaI-VMP1 mouse acini treated with these inhibitors (Fig. 3, E
and F). Interestingly, these experiments demonstrated that
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the inhibition of autophagic flow markedly increased trypsin
activity within acinar cells in ElaI-VMP1 mouse pancreata.
These results confirm that zymophagy specifically degrades
those zymogen granules that are initially activated by acute
pancreatitis preventing the irreversible spreading of activated
trypsin into the acinar cell cytoplasm, a phenomenon that
ultimately leads to cell death.
Zymophagy Protects Acinar Cells from Intracellular Tryp-
sinogen Activation Triggered in Vivo by Experimental
Pancreatitis—Activated trypsin within the acinar cell is con-
sidered to contribute importantly to the deleterious effects of
acute pancreatitis (31). Consequently, we evaluated the patho-
physiological relevance of zymophagy during cerulein-in-
duced acute pancreatitis in mice (32). We first monitored aci-
FIGURE 2. Inducible and selective sequestration of zymogen granules by VMP1-mediated autophagic pathway. A, immunofluorescence assay using
anti-LC3 and anti-trypsinogen antibodies on pancreatic acini isolated from ElaI-VMP1 mice. Top row, untreated isolated acini. No colocalization between
LC3 and trypsinogen is observed in acinar cells. A detail of granular areas is shown on the upper left side. Bottom row, cerulein-mediated CCK-R hyperstimu-
lated isolated acini. Remarkable colocalization between LC3 and zymogen granules is found in acinar cells. Colocalization examples are detailed. DIC, differ-
ential interference contrast. B–D, isolation of autophagosomes using anti-GFP antibody bound magnetic beads from postnuclear supernatant of ElaI-VMP1
mouse pancreas homogenates. B, we show two examples of VMP1-EGFP autophagosomes containing zymogen granules isolated from CCK-R hyperstimu-
lated mouse pancreas homogenates. These double membrane structures containing zymogen granules are detailed in left panel. C, two examples of VMP1-
EGFP-coated structures from untreated ElaI-VMP1 mouse pancreas homogenates. Empty or cytoplasm-containing simple or double membrane structures
are observed and detailed (right panel). D, quantitative analysis indicates that less than 20% of autophagosomes containing zymogen granules are isolated
from untreated animal pancreata, and more than 70% of autophagosomes containing zymogen granules are isolated from CCK-R hyperstimulated
mouse pancreata (**, p  0.001 versus untreated). E, Western blot analysis using anti-LC3, anti-trypsinogen, and anti-p62 antibodies of magnetically
immunopurified autophagosomes from CCK-R-hyperstimulated ElaI-VMP1 mouse pancreas homogenates (cerulein lane) compared with autophago-
somal fraction obtained from untreated mouse pancreas (untreated lane). The presence of LC3-II (16 kDa) confirms that all the isolated structures are
autophagosomes. Zymogen granules as cargo of such autophagosomes are evidenced by trypsinogen-positive blot in autophagosomal fraction iso-
lated from CCK-R-hyperstimulated mouse pancreas. The presence of p62 suggests selective autophagosomes and p62-mediated cargo recognition.
Results are representative of at least three independent experiments. Scale bars, 10 m (A), and 0.5 m (B and C).
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nar cell injury using enzymatic markers, such as serum
amylase and lipase activities (Fig. 4A). No significant differ-
ences of these serum enzymatic patterns were found in un-
treated mice (wild type and ElaI-VMP1 mice). Upon CCK-R
hyperstimulation, wild type mice developed acute pancreatitis
with high amylase and lipase serum levels. On the contrary,
FIGURE 3. Zymophagy is inducedbyCCK-Rhyperstimulation to selectively sequester anddegrade activated zymogengranules. Intracellular activation of
trypsinogen in isolated pancreatic acini was detected by BZiPAR reagent (see “Experimental Procedures”).A and B, trypsin activity in isolated pancreatic acini be-
fore (top row), 30min after (middle row), and 1 h after (bottom row) cerulein CCK-R hyperstimulation. Activated trypsin is evidenced by red spots of hydrolyzed sub-
strate. A, acini fromwild typemice; early trypsinogen activation is evidentwithin acinar cells during the course of CCK-R hyperstimulation. B, acini from ElaI-VMP1
mice; no activity of trypsin is found after 30min of CCK-R hyperstimulation, and only few spots of hydrolyzed substrate are detectedwithin acinar cells after 1 h of
treatment. EGFP-VMP1 fluorescence shows relocation of VMP1 to the granular area of acinar cells in ElaI-VMP1 pancreatic acini after CCK-R hyperstimulation.
C, quantification of trypsin activity in homogenates from isolated pancreatic acini during CCK-R hyperstimulation. Acini from ElaI-VMP1mice show significantly less
trypsinogen activation comparedwithwild typemice (**, p 0.001 versuswild type).D, remarkable colocalization between hydrolyzed trypsin substrate (red spots)
and VMP1-EGFP fluorescent signals is seen in acinar cells from ElaI-VMP1mice after 1 h of CCK-R hyperstimulation.Merge image in look-up table (LUT) pseudocolor
and two hot fluorescence spots profile are shown to prove specific colocalization. E, trypsinogen activation in ElaI-VMP1 pancreatic acini treatedwith chloroquine
or vinblastine after 1 h of CCK-R hyperstimulation. Red fluorescence spots show increased trypsin activity within acinar cells submitted to both autophagy inhibi-
tory treatments (chloroquine and vinblastine). F, trypsinogen activationwas quantified as percentage ofmaximal trypsin activity inwild typemice pancreatic acini
under cerulein CCK-R hyperstimulation. The protective effect of VMP1-autophagy pathway on trypsinogen activation in ElaI-VMP1 acini upon cerulein CCK-R hy-
perstimulation (ElaI-VMP1 vehicle bar) is significantly reversed by autophagy inhibitors (chloroquine and vinblastine treatment bars); (**, p 0.001 versus ElaI-
VMP1 vehicle bar). No significant differences are observed between vehicle and autophagic flow inhibitors inwild type acini treatedwith cerulein. Error bars indi-
cate standard deviation of at least three independent experiments. Scale bars, 20m.
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enzymatic levels in cerulein-treated ElaI-VMP1 mice were
significantly lower compared with wild type mice. Consis-
tently, ElaI-VMP1 mouse pancreata showed remarkably less
macroscopic evidence of acute pancreatitis compared with
wild type animals, which showed marked edema and hemor-
rhage (Fig. 4B). We performed light microscopy examination
of cerulein-treated ElaI-VMP1 and wild type mouse pancre-
atic tissues through paraffin sections stained with H&E (Fig.
4C) and thin plastic sections stained with toluidine blue (Fig.
4D). Histological analyses displayed a high degree of necrosis
as well as infiltration in wild type pancreata with acute pan-
creatitis. In contrast, neither evidence of necrosis (Fig. 4E) nor
significant inflammation (Fig. 4, F and G) was seen in ceru-
lein-treated ElaI-VMP1 mice. Thus, results obtained in the
FIGURE 4. Zymophagy protects acinar cells from trypsinogen (TG) activationmediated by CCK-R hyperstimulation in vivo. Experimental acute pan-
creatitis was induced in mice by CCK-R hyperstimulation with cerulein. A, amylase and lipase activities in serum from wild type and ElaI-VMP1 mice after
cerulein treatment in a time course scheme showing significantly reduced enzyme levels in ElaI-VMP1 mice. B,macroscopic photographs of freshly re-
moved pancreata from wild type and ElaI-VMP1 mice after experimental acute pancreatitis. C, light microscopy of pancreatic tissue from cerulein-treated
wild type and ElaI-VMP1 mice using paraffin sections stained with H&E. D, thin plastic section of wild type and ElaI-VMP1 pancreata stained with toluidine
blue at increasing magnifications. Images show high degree of necrosis (*) as well as infiltration (arrows) in wild type mice after 6 h of acute pancreatitis. In
contrast, almost no inflammation or evidence of necrosis is seen in cerulein-treated ElaI-VMP1 mice. E, necrosis quantification determined in H&E specimens
as necrotic cells per 100 acinar cells. F, infiltration quantified in H&E specimens as number of inflammatory cells per 100 pancreatic acinar cells. G,myeloper-
oxidase (MPO) activity determined in pancreas homogenates. Error bars indicate standard deviation of at least three independent experiments (*, p 0.05;
**, p 0.001 versuswild type). Scale bars, 0.5 cm (B), and 20 m (C and D).
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animal model showed that zymophagy functions as a protec-
tive pathophysiological mechanism against pancreatitis-asso-
ciated injury.
Zymophagy Prevents Pancreatic Acinar Cell Death Induced
by CCK-R Hyperstimulation—To further understand the
mechanism of zymophagy, we used the rat acinar cell line
AR42J, the best characterized pancreatic acinar cell culture
model. To obtain differentiated acinar cells, we treated AR42J
cells with 100 nM dexamethasone (20), and granules stained
positive for amylase were evidenced after 48 h of treatment
(Fig. 5A). We used these cells to mimic the responses ob-
served in acute pancreatitis and to recapitulate several as-
pects of zymophagy. In fact, CCK-R hyperstimulation in-
duced endogenous VMP1 expression and recruited the
autophagic marker RFP-LC3 (Fig. 5, B and C). We then
knocked down VMP1 in this acinar cell line model using a
specific short hairpin RNA construct (shVMP1) into the
pCMS3-H1p-EGFP plasmid, which has a separate tran-
scriptional cassette for EGFP to identify transfected cells
(23). Knockdown experiments demonstrated that the
VMP1-mediated autophagy pathway induced by CCK-R
hyperstimulation is intact in this cell model, because re-
duced levels of this protein clearly decreased the recruit-
ment of fluorescent RFP-LC3 (Fig. 5D). Subsequently, to
elucidate whether zymophagy modulates cell death as a
response to CCK-R hyperstimulation, we used both phar-
macological and genetic (shVMP1) tools in differentiated
AR42J cells. Pharmacological inhibition of autophagy initi-
ation and autophagic flow was performed using 3-MA and
chloroquine, respectively. Fig. 5E shows that autophagy
inhibitors significantly reduced cell survival under CCK-R
hyperstimulation. Moreover, VMP1 down-regulation (sh-
VMP1) also significantly decreased acinar cell survival un-
der CCK-R hyperstimulation (Fig. 5F) showing that VMP1
expression is required to prevent acinar cell death in acute
pancreatitis. These results indicate that zymophagy pre-
vents pancreatic cell death induced by the activation of
zymogen granules and confirm that endogenous VMP1
expression is activated in acinar cells to mediate zymophagy as a
protective cellular response against cell death.
During Zymophagy the Ubiquitin System Serves as a Target-
ing Signal for Zymogen Granules—Proteins involved in the
recognition of target for autophagy are ubiquitin-binding pro-
teins, such as p62, that binds directly to ubiquitin and LC3.
Indeed, as shown in Fig. 2E, magnetically purified VMP1-me-
diated autophagosomes upon CCK-R hyperstimulation con-
tain p62 and LC3 proteins. This finding suggests that the
ubiquitin system may serve as a signal for the selective rec-
FIGURE 5. Zymophagy prevents acinar pancreatic cell death induced by CCK-R hyperstimulation. Rat acinar cell line AR42J differentiated by treatment
with 100 nM dexamethasone. A, immunofluorescence assays using anti-amylase antibody evidencing presence of zymogen granules in the AR42J cell line
after 48 h of dexamethasone treatment. B, cerulein-treated AR42J differentiated cells show LC3-I to LC3-II conversion (Western blot analysis) and RFP-LC3
aggregation, evidencing autophagy triggered by CCK-R hyperstimulation (*, p 0.05 versus untreated). C, both VMP1 transcript and VMP1 protein are in-
duced early in differentiated AR42J cells under cerulein CCK-R hyperstimulation. Results are representative of three independent experiments. D, shRNA
mediated down-regulation of VMP1 in cerulein-treated differentiated AR42J cells cotransfected with pRFP-LC3. Green cells with reduced VMP1 expression
show a diffuse RFP-LC3 pattern upon CCK-R hyperstimulation, indicating the absence of autophagy in VMP1 silenced cells. On the contrary, VMP1 express-
ing cells present aggregated RFP-LC3 in response to cerulein CCK-R hyperstimulation, evidencing autophagy induction. E, CCK-R hyperstimulation with
cerulein promotes a nearly 50% reduction in cell viability. Disruption of the autophagy process at early steps with 3MA or at late steps with chloroquine
(CQ) significantly decreases cell viability under CCK-R hyperstimulation (**, p 0.001 versus control). F, inhibition of the VMP1-autophagy pathway by
down-regulation of VMP1 expression with shVMP1 significantly decreases viability of cerulein-treated AR42J cells (*, p 0.05 versus cerulein-treated VMP1
expressing cells). Error bars indicate standard deviation of at least three independent experiments. Scale bars, 10 m. DIC, differential interference contrast.
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ognition of zymogen granules by autophagosomes during
zymophagy. To test this hypothesis, we first analyzed if
zymogen granules are ubiquitinated under CCK-R hyper-
stimulation. We transfected acinar cells with GFP-ubiquitin
(GFP-Ub) expression plasmid and then performed CCK-R
hyperstimulation. After 15 min of treatment, cells were fixed
for immunofluorescence assays to detect ubiquitin, amylase,
and trypsinogen. We found high colocalization of ubiquitin
with amylase and with trypsinogen (Fig. 6A). We then investi-
gated whether ubiquitinated granules are sequestered by
VMP1-mediated selective autophagosomes. In complemen-
tary experiments, we concomitantly transfected acinar cells
with pRFP-LC3 and GFP-Ub plasmids and then performed
CCK-R hyperstimulation. Noteworthy, fluorescence analyses
showed recruitment of ubiquitin and LC3 and ubiquitin signal
within LC3 decorated vesicles after 15 min of treatment, indi-
cating the autophagic engulfment of ubiquitinated granules
(Fig. 6B). We next cotransfected cells with VMP1-EGFP and
RFP-Ub to analyze if VMP1-mediated autophagosomes selec-
tively sequester ubiquitinated granules. We found marked
colocalization between VMP1 and ubiquitinated granules and
engulfment of ubiquitinated granules by VMP1 vesicles. This
FIGURE 6. Ubiquitin system serves as a target signal for zymogen granules during zymophagy. Dexamethasone-differentiated AR42J cells were evalu-
ated for ubiquitin participation in the zymophagy process. A, differentiated AR42J cells transfected with GFP-Ub expression plasmid were subjected to ceru-
lein treatment for 30 min, and immunofluorescence assays were made using anti-amylase and anti-trypsinogen antibodies as zymogen granules markers.
Large aggregates of ubiquitin and zymogen granules are observed in cell cytoplasm upon CCK-R hyperstimulation. B, acinar cells concomitantly transfected
with pRFP-LC3 and GFP-Ub expression plasmids during CCK-R hyperstimulation. Both proteins remain with a diffuse pattern in untreated cells. After 15 min
of cerulein treatment there is recruitment of ubiquitin inside LC3 vesicles (detailed), indicating the autophagic engulfment of ubiquitinated granules.
C, differentiated AR42J cells cotransfected with pEGFP-VMP1 and pRFP-Ub expression plasmids. Almost no colocalization and diffuse ubiquitin pattern is
shown in untreated acinar cells. Under cerulein-mediated CCK-R hyperstimulation, the engulfment of large ubiquitin aggregates by VMP1-vesicles is ob-
served (see details on the right). D, trypsin activity evaluated by BZiPAR specific fluorescent substrate in GFP-Ub transfected acinar cells. Neither trypsin ac-
tivity nor ubiquitin aggregation is evident in untreated cells. Colocalization between activated zymogen granules and ubiquitin in cerulein-treated cells
indicates that ubiquitin system serves as a recognition signal during zymophagy. Results are representative of three independent experiments. Scale bars,
10 m.
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confirms the selective sequestering of ubiquitinated zymogen
granules by zymophagy (Fig. 6C). More importantly, we inves-
tigated if these selectively sequestered ubiquitinated granules
are those activated by CCK-R hyperstimulation. We mea-
sured trypsin activity using the fluorescent substrate BZiPAR
in GFP-Ub-transfected acinar cells subjected to CCK-R hy-
perstimulation. Fig. 6D shows colocalization between acti-
vated granules and ubiquitin aggregates, indicating that the
ubiquitin system serves as a target signal for activated zymo-
gen granules during zymophagy. These results demonstrate
that activated granules are ubiquitinated and sequestered by
the VMP1-mediated selective autophagic process and suggest
that the ubiquitin system has an important role in
zymophagy.
VMP1 Interacts with USP9x Ubiquitin-Protease, which Is
Required for Zymophagy—Using a yeast two-hybrid screening
strategy looking for VMP1 interactors, we found in 4 clones of
29 sequenced positive clones the USP9x protein (data not
shown). We then studied USP9x expression in the cell model
of acute pancreatitis. Interestingly, USP9x expression is highly
induced in AR42J cells under CCK-R hyperstimulation (Fig.
7A). We also studied whether VMP1 interacts with USP9x
using coimmunoprecipitation assays with a VMP1-V5-His6-
tagged protein. This experiment demonstrated that USP9x
interacts with VMP1 in AR42J cells upon CCK-R hyperstimu-
lation. The amount of coimmunoprecipitated USP9x was
maximal after 0.5 h and decreased markedly after 1 h treat-
ment (Fig. 7B, top panel). To further test VMP1-USP9x inter-
FIGURE 7. VMP1 interacts with USP9x ubiquitin-protease, which is required for zymophagy. A, RT-PCR of USP9x transcript in AR42J acinar cells. No dif-
ferences in USP9x expression are observed between the nondifferentiated and dexamethasone-differentiated cells. Interestingly, USP9x expression is
highly induced in dexamethasone differentiated AR42J cells under cerulein CCK-R hyperstimulation. B, coimmunoprecipitation assay using a VMP1-V5-His6-
tagged protein. Differentiated AR42J cells were alternatively treated with cerulein or cerulein and vinblastine. After purification, immunoblotting using anti-
V5, anti-USP9x, and anti-p62 were made on the unbound fraction (S1), eluate (E), and second wash (W2). After 30 min of CCK-R hyperstimulation, VMP1-
USP9x interaction is evident, and it decreases markedly after 1 h of cerulein treatment. Upon autophagic flow inhibition (vinblastine treatment), a higher
USP9x signal is present at the 1-h cerulein treatment eluate. In none of these experiments was VMP1-p62 interaction observed. C, immunofluorescence as-
says of VMP1 and USP9x in differentiated AR42J cells shows that both proteins colocalize in vesicle structures within the zymogen granule-rich area of aci-
nar cells after 30 min of cerulein CCK-R hyperstimulation. D, endogenous VMP1 and USP9x induced by CCK-R hyperstimulation coimmunoprecipitate (IP) in
differentiated AR42J cells using anti-VMP1 antibody. E, cells concomitantly transfected with expression plasmids for shUSP9x and RFP-LC3, subjected to
cerulein CCK-R hyperstimulation or to starvation. Upper panel, cells expressing USP9x show LC3 recruitment after cerulein treatment.Middle panel, down-
regulation of USP9x (green cell) clearly abolished LC3 recruitment to autophagosomes after cerulein treatment. Bottom panel, down-regulation of USP9x
(green cell) is not able to avoid starvation-induced LC3 recruitment. F, differentiated AR42J cells alternatively transfected with VMP1-EGFP or shUSP9x. Eval-
uation of zymogen granule activation using BZiPAR fluorescence substrate during cerulein CCK-R hyperstimulation. VMP1 expression significantly reduces
the amount of trypsin activity under CCK-R hyperstimulation. The shRNA-mediated knockdown of USP9x expression significantly increases trypsin activity
within acinar cells compared with untransfected cells (*, p 0.05 versus empty vector). Error bars indicate standard deviation of at least three independent
experiments. Scale bars, 10 m.
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action, we repeated these experiments in vinblastine pre-
treated cells that accumulate autophagosomes. Under this
condition, we observed that the USP9x-VMP1 coelution is
more evident after 1 h of treatment, confirming this interac-
tion in zymophagy (Fig. 7B, bottom panel). Similar experi-
ments demonstrated that despite the fact that p62 participates
in zymophagy, because it is present in magnetically purified
VMP1-selective autophagosomes, this protein does not inter-
act with VMP1 (Fig. 7B). We also analyzed the localization of
endogenous VMP1 and USP9x in CCK-R-hyperstimulated
acinar cells. Fig. 7C shows that endogenous VMP1 and USP9x
colocalize in vesicle structures within the zymogen granule-
rich area of acinar cells after 0.5 h of CCK-R hyperstimula-
tion. We next tested whether the endogenous proteins, VMP1
and USP9x, interact during zymophagy. Using anti-VMP1
antibody, we found that endogenous VMP1 and USP9x coim-
munoprecipitate in differentiated AR42J cells subjected to
CCK-R hyperstimulation (Fig. 7D). These results further con-
firm the existence of a novel VMP1-USP9x interaction. To
analyze the functional relevance of USP9x in zymophagy, we
knocked down USP9x in the differentiated AR42J acinar cells
using a specific short-hairpin RNAi construct (shUSP9x)
cloned into a GFP-expressing plasmid to identify transfected
cells (23). Cells were concomitantly transfected with expres-
sion plasmids for shUSP9x and RFP-LC3 and subjected to
CCK-R hyperstimulation or to nutrient deprivation. Fig. 7E
shows that USP9x down-regulation clearly abolished LC3 re-
cruitment to autophagosomes when the selective autophagy
was induced by CCK-R hyperstimulation (zymophagy). These
findings indicate that USP9x is required for zymophagy. On
the contrary, USP9x down-regulation failed to abolish LC3
recruitment when autophagy was induced by starvation, indi-
cating that the identified pathway was not involved in a gen-
eral form of autophagy.
Finally, we wondered if USP9x-VMP1 interaction is re-
quired for the protective role of the zymophagy process. To
accomplish this objective, we evaluated zymogen granule acti-
vation during CCK-R hyperstimulation in differentiated
AR42J cells using the fluorescent substrate BZiPAR. Fig. 7F
shows that VMP1 expression significantly reduces the
amount of trypsin activity under CCK-R hyperstimulation. In
the same conditions, down-regulation of USP9x significantly
increased trypsin activity within acinar cells. This signals that
USP9x is required for the protective role of VMP1-mediated
zymophagy. To summarize, our results so far suggest that
zymophagy requires the ubiquitin system by implying VMP1-
USP9x interaction in its protective cell function.
Structural and Biochemical Features of Zymophagy Are Pre-
served in Humans—Given the importance of zymophagy in
acinar cells from mouse pancreata, mouse isolated pancreatic
acini, and differentiated cultured cells, we investigated
whether this protective and selective form of autophagy oc-
curs in human acute pancreatitis. We studied normal and
pancreatitis-affected acinar cells using immunofluorescence
assays of VMP1, LC3, p62, and trypsinogen. Normal tissue
areas (A0) presented diffuse LC3 signal and undetectable
VMP1 expression, evidencing very low levels of autophagy
(Fig. 8A, top row). On the other hand, acini from pancreatitis-
affected areas (A1), in which loss of cell polarity, edema, and
detachment of acinar cells are characteristic morphological
features, presented marked expression of VMP1. In these ar-
eas, VMP1 highly colocalized with LC3, and VMP1-LC3 au-
tophagosomes were observed in the granular area of acinar
cells (Fig. 8A, middle and bottom rows). Quantification of LC3
recruitment and VMP1 expression confirmed that VMP1 ex-
pression is activated during human acute pancreatitis, and its
expression is related to the induction of autophagosome for-
mation in affected pancreata (Fig. 8B). In accordance to the
already described results, VMP1-p62 colocalization further
reveals the induction of the VMP1-mediated selective auto-
phagic pathway in pancreatitis-affected human pancreatic acinar
cells (Fig. 8C). Immunofluorescence assays for defining the
localization of trypsinogen and LC3 showed the presence of
autophagosomes containing zymogen granules in pancreati-
tis-affected acini of human specimens (Fig. 8D). Combined,
our results demonstrate for the first time in the human pan-
creas the existence of VMP1-mediated selective autophagy,
i.e. zymophagy, as a cell response to disease.
Finally, we characterized the autophagy progression in hu-
man pancreas by performing immunofluorescence assays of
Lamp2, a specific lysosomal marker. In normal areas of the
pancreas (A0) small lysosomal structures are detected,
whereas in affected areas (A1) Lamp2-trypsinogen colocaliza-
tion and often large lysosomal structures with no signal of
trypsinogen are seen and detailed (Fig. 9). These features are
characteristic of autolysosomal structures at different matura-
tion levels, suggesting that zymophagy eventually leads to the
complete degradation of sequestered zymogen granules
within the autolysosome. These findings in human specimens
collectively support our in vitro and in vivo results, revealing
that zymophagy is an evolutionarily conserved mechanism of
cellular response to disease.
DISCUSSION
Our work has led us to reveal a novel type of selective au-
tophagy, i.e. zymophagy, in which VMP1 and USP9x are key
functional components. Zymophagy is characterized by the
formation of autophagosomes containing zymogen granules.
These organelles mediate the sequestration and degradation
of pancreatitis-activated zymogen granules and are induced
by secretagogues and probably other stimuli in acinar cells.
EM and immunofluorescence assays in human, mouse, and
cultured pancreatic acinar cells show autophagic organelles at
different maturation levels, suggesting that the autophagic
flow progresses to acquire autolysosomal features and de-
grades the disease-altered secretory granules. Moreover, deg-
radation of p62 during the course of zymophagy outlines the
functionality of the autophagic pathway. These findings fur-
ther confirm that selectively sequestered zymogen granules
are completely degraded by zymophagy. This type of selective
autophagy that is preserved in humans behaves as a protective
cell mechanism against the acinar cell self-digestion and con-
sequent progression of pancreatitis. Therefore, our investiga-
tion discloses a new selective autophagy pathway as a cellular
and molecular mechanism implicated in human disease. This
study also provides an insight into cell biology, demonstrating
Zymophagy
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a role for the VMP1-mediated autophagy in secretory granule
homeostasis and in response to cell death. This acknowledg-
ment implicates VMP1 in a previously unknown cellular func-
tion that is distinct from its already described essential role in
the early steps of autophagosome formation. Furthermore,
zymophagy is a form of selective autophagy induced by hyper-
stimulation of Gq-coupled receptors and represents the only
inducible type of autophagy described thus far in secretory
cells.
The results from our work position VMP1 and p62 in the
same selective autophagy pathway. Immunofluorescence as-
says and Western blot analyses of proteins from isolated se-
lective autophagosomes demonstrate that these proteins colo-
calize and coexist in this autophagic organelle suggesting that
p62 may act as a cargo receptor during the VMP1-selective
autophagic pathway. The marked colocalization of ubiquitin
with activated zymogen granules in the acinar cell subjected
to CCK-R hyperstimulation supports this hypothesis. In addi-
tion, the localization of ubiquitin within LC3-positive, VMP1-
formed autophagosomes indicates that ubiquitinated cargo is
sequestered by zymophagy. Therefore, activated zymogen
granules might be directly or indirectly ubiquitinated for their
recognition by autophagic membranes, in which ubiquitin
would act as a label for selective engulfment. This label might
be subsequently removed for completing the formation of the
autophagosome or even before this engulfment step. Never-
theless, our results strongly support the hypothesis that acti-
vated granules are ubiquitinated upon CCK-R hyperstimula-
tion, and these ubiquitinated granules are sequestered by the
VMP1-mediated selective autophagic pathway.
Notably, we identified USP9x as an essential component of
the machinery required to selectively degraded zymogen
granules during pancreatitis. The USP9x gene is a member of
the peptidase C19 family and encodes for a ubiquitin-specific
FIGURE 8. Structural and biochemical features of zymophagy are preserved in humans. Immunofluorescence assays of VMP1, LC3, p62, and trypsino-
gen in acute pancreatitis human specimens (acini are limited by dashed lines). A, top row, nonaffected acini (A0) show diffused LC3 and undetectable VMP1.
Middle and bottom rows, pancreatitis-affected areas (A1) of human pancreas specimens show VMP1 expression that markedly colocalizes with LC3 in granu-
lar areas of acinar cells. B, quantification of autophagy as percentage of cells with both VMP1-positive staining and punctate LC3 per 100 acinar cells in A0
and A1 areas. Significant VMP1 expression colocalizing with aggregated LC3 is observed in affected tissue areas. Staining was counted in six random fields
and expressed as mean S.D. of three independent experiments (**, p 0.001 versus A0). C, VMP1-p62 colocalization in affected tissue areas, suggests p62
participation in VMP1-mediated zymophagy in human pancreatitis (lines specify higher magnification images). D, LC3 and trypsinogen immunostaining in
affected acini show the presence of autophagosomes containing zymogen granules (zymophagy) in pancreatitis-affected acini. When specified by lines,
higher magnification images are shown. Scale bars, 10 m. DIC, differential interference contrast; N, nucleus.
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protease. Ubiquitinating and deubiquitinating enzymes have
emerged as key players in the regulation of membrane traf-
ficking in organisms ranging from yeasts to mammals (33).
Our data support the idea that there is a close cooperation
between the autophagy pathway and the ubiquitin machinery
required for selective autophagy. Our results demonstrate
that USP9x is required to promote the selective degradation
of altered zymogen granules. Interestingly, VMP1 interacts
with USP9x early during zymophagy, supporting a direct
functional role for this ubiquitin-specific protease in this se-
lective autophagic pathway. Furthermore, down-regulation of
USP9x abolished activated zymogen granule degradation in
acinar cells under CCK-R hyperstimulation, confirming the
essential role of VMP1-USP9x interaction for zymophagy.
USP9x is likely to modulate zymogen granule-selective en-
gulfment during acute pancreatitis by modulating VMP1 or
providing a preferential recognition signal for altered zymo-
gen granules. These data demonstrate for the first time that
ubiquitin modifications may possess an additional function in
acinar cells by promoting the degradation of highly harmful
activated zymogen granules. Alternatively, both ubiquitina-
tion and deubiquitination of distinct critical molecules
might be required for selective autophagy. Thus, because of
the potential importance of this type of regulation, this
study may fuel future investigations aimed to identify the
potential E3 ligases and ubiquitinated substrate(s) required
for zymophagy.
Our findings provide further understanding of the molecu-
lar mechanisms relevant to human diseases, particularly acute
pancreatitis. This condition has classically been considered an
autodigestive disorder where the inappropriate activation of
trypsinogen within the pancreatic acinar cell leads to the pro-
FIGURE 9. Zymophagy leads to the complete degradation of sequestered zymogen granules within the autolysosome. Immunofluorescence assays
of Lamp2 and trypsinogen in acute pancreatitis human specimens (acini are limited by dashed lines). The top row shows small lysosomal structures labeled
with Lamp2 in unaffected areas. In themiddle row, Lamp2 and trypsinogen signals show colocalization between lysosome and zymogen granule markers.
Colocalization examples are detailed, indicating that sequestered granules reach lysosomes (early autolysosomes). In the bottom row, Lamp2 and
trypsinogen signals show large lysosomes without trypsinogen (magnification) suggesting that zymogen granules are eventually degraded in this
acidic organelle (late large autolysosomes). Lines specify higher magnification images. Results are representative of at least three independent ex-
periments. Scale bars, 10 m.
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gression of the disease. However, the exact mechanism for the
initiation of zymogen granule activation remains a subject of
intensive investigation and debate after more than 5 decades
of research efforts (34, 35). Similarly, the role of autophagy in
pancreatitis is seemingly incomplete, sometimes contradic-
tory, and requires further investigations. For instance,
Hashimoto et al. (36) and Mareninova et al. (37) propose that
autophagy is responsible for the zymogen activation within
the acinar cell during acute pancreatitis. These suggestions
are based on the finding that deletion of the Atg5 gene in pan-
creatic cells prevents acute pancreatitis. Unfortunately, this
observation is currently questioned by the knowledge that
ATG5 has other implications not related to autophagy; in fact,
when proteolytically activated, it becomes a pro-apoptotic
molecule (38). Moreover, cells lacking Atg5 and Atg7 can still
perform autophagy-mediated protein degradation (39), dem-
onstrating that deletion of these genes does not completely
abolish autophagy. These data also introduce the question
whether the role of different types of autophagy, similar to the
one remaining in the Atg5 knock-out mice, have an impact on
pancreatitis. In this regard, we describe that this selective
form of VMP1-induced autophagy (zymophagy), triggered by
CCK-R hyperstimulation, is not inhibited, sequesters acti-
vated zymogen granules, and protects from acute pancreatitis.
Therefore, these results significantly extend our current
knowledge on autophagy by demonstrating that the outcome
of pancreatitis differs when different types of autophagy path-
ways are considered, including selective and nonselective
ones.
Our results demonstrate also for the first time that there is
activation of the VMP1-autophagic pathway and zymophagy
during human pancreatitis. These findings lead us to discuss
how this knowledge fits the current theoretical framework
regarding the occurrence and progression of this disease.
Acute pancreatitis is a frequent, painful, and often deadly dis-
ease that ranges from a mild, edematous, and autolimited
process to a severe necrotizing and eventually lethal condi-
tion. Additionally, the etiology of this disease is diverse, and
different stimuli can initiate the same autodigestion cascade
via different mechanisms (40). Our data show that there is
expression of VMP1 during acute pancreatitis in humans, and
there is formation of autophagosomes where p62, LC3, and
zymogen granules colocalize. Altogether, our findings indi-
cate that zymophagy also occurs in human pancreatitis. This
protective cell response could explain, at least in part, the
auto-limited form of this disease seen in many patients. Hence,
it is tempting to speculate that the more efficient zymophagic
response by the pancreatic acinar cell, the less severity of the
disease. In contrast, severe forms of pancreatitis offering an
excess of cargo and an accelerated rate of degradation might
overcome or disrupt the protective capacity of this selective
autophagic process. The latter possibility is suggested by our
results because the inhibition of the autophagic flow impairs
the protective role of zymophagy. The findings of Fortunato
and Kroemer (41), regarding the reduction of the autophago-
some-lysosome fusion in human alcoholic pancreatitis, fur-
ther support our hypothesis.
Finally, this novel autophagic pathway that selectively de-
grades altered secretory granules might be involved in other
pathological processes affecting secretory cells, such as pan-
creatic beta cells in diabetes mellitus or Paneth cells in Crohn
disease. Therefore, more studies on autophagy as a pro-
grammed cell response to pathological processes that affect
protein secretion are important to significantly expand our
knowledge of the role of autophagy in both cell biology and
human disease.
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